BPIQ Blog

$XBI $81.16 | -4.3% Covid Updates $NRXP -13.2% NRx Pharmaceuticals Files New Breakthrough Therapy Designation Request for ZYESAMI®...

$XBI $84.79 | +0.22% Covid Updates $AZN +0.8% Evusheld significantly protected against symptomatic COVID-19 for at least six months in...

$XBI $84.60 | +1.21% Covid Updates $MRNA -1.3% Moderna Announces Clinical Update on Bivalent COVID-19 Booster Platform. source $NVAX...

$XBI $83.59 | -4.76% Covid Updates $OCGN -5.8% Ocugen, Inc. to Commercialize COVAXIN™ in Mexico, Rights Now Encompassing All of North...

$XBI $87.77 Pipeline Updates $TGTX TG Therapeutics Announces Voluntary Withdrawal of the BLA/sNDA for U2 to Treat Patients with CLL and...

$XBI $87.77 | -2.92% Covid Updates $PFE 0,0% & -2.3% BNTX Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following...

$XBI $90.41 | +3.8% Covid Updates $NVAX +7.0% Swissmedic Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine. source...

$XBI $87.15 | -.019% Covid Updates $ Pipeline Updates $TPTX +0.6% Turning Point Therapeutics Announces Positive Topline Data by Blinded...

$XBI $87.32 | -3.34% Covid Updates $ Pipeline Updates $AGLE -6.5% Aeglea BioTherapeutics Presents Additional Data from PEACE Phase 3...

$XBI $90.34 | +-2.3% Covid Updates $NVAX +1.9% Novavax and Serum Institute of India Receive Emergency Use Authorization for Novavax'...

$XBI $92.43 | -0.96% Covid Updates $ Pipeline Updates $MNOV +3.9% MediciNova Announces Secondary Analysis of Phase 2 Trial of MN-166...

$XBI $93.33 | +0.086% Covid Updates $ Pipeline Updates $SPRO -4.1% Spero Therapeutics Tebipenem Pivoxil Hydrobromide Phase 3 Data...

$XBI $93.25 | -2.96% Covid Updates $TNXP -4.9% Tonix Pharmaceuticals Announces Extension of Sponsored Research Agreement with Kansas...

$XBI $96.09 | +3.0% Covid Updates $ALGS +4.0% Aligos Therapeutics Selects Drug Candidate ALG-097558, a Potent Ritonavir-Free Oral...

$XBI $93.26 | +3.76% Pipeline Updates $CYTK Cytokinetics Announces Results From Cohort 3 of Redwood-HCM Presented at American College of...

$XBI $89.88 | -0.88% Covid Updates $SRNE -1.7% Sorrento Reports FDA Clearance for the Commencement of a Phase 2/3 Study for Abivertinib...

$XBI $90.68 | -3.07% Covid Updates $CYDY +0.8% CytoDyn Announces Partial Clinical Hold of HIV Program and Full Clinical Hold of COVID-19...

$XBI $93.55 | +4.28% Covid Updates $BNTX +3.6% & $PFE -1.0% Pfizer and BioNTech Receive Expanded U.S. Emergency Use Authorization for...

$XBI $89.71 | +0.1% Covid Updates $ Pipeline Updates $NBIX -0.1% Neurocrine Biosciences Announces Regulatory Approval of Dysval®...

$XBI $89.62 | -2.34% Covid Updates $VIR US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to...